The HDAC inhibitor panobinostat (LBH589) exerts in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia and involves the RNF20/RNF40/WAC-H2B ubiquitination axis.
about
The HDAC inhibitor panobinostat (LBH589) exerts in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia and involves the RNF20/RNF40/WAC-H2B ubiquitination axis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
The HDAC inhibitor panobinosta ...... 0/WAC-H2B ubiquitination axis.
@en
type
label
The HDAC inhibitor panobinosta ...... 0/WAC-H2B ubiquitination axis.
@en
prefLabel
The HDAC inhibitor panobinosta ...... 0/WAC-H2B ubiquitination axis.
@en
P2093
P2860
P356
P1433
P1476
The HDAC inhibitor panobinosta ...... 0/WAC-H2B ubiquitination axis.
@en
P2093
E H J van Roon
G Te Kronnie
M Kerstjens
O Heidenreich
P Garrido Castro
P Schneider
S S Pinhanços
P2860
P2888
P356
10.1038/LEU.2017.216
P577
2017-07-10T00:00:00Z
P6179
1090594628